Robin Choudhury is Professor of Cardiovascular Medicine at the University of Oxford and Consultant Cardiologist at the John Radcliffe Hospital. He trained in Oxford, London and at Mount Sinai in New York. His research focuses on inflammation and cardiovascular disease, and he is co-Principal Investigator of the Novo Nordisk–supported MeRIAD consortium. He also serves as Joint Clinical Lead for the MRC-BHF Centre of Research Excellence in Advanced Cardiac Therapies and is UK Chief Investigator for the ZEUS clinical trial of ziltivekimab. Robin is a Research Fellow at Balliol College and an Affiliated Researcher in regenerative medicine.